Virtus ETF Advisers’s Elevance Health ELV Stock Holding History

Virtus ETF Advisers’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,678	Closed	-$873K	–	478
2024 Q3	$873K	Buy	+1,678	New	+$896K	0.41%	118
2023 Q3	–	Sell	-1,702	Closed	-$756K	–	450
2023 Q2	$756K	Sell	1,702 -155	-8%	-$71.5K	0.45%	86
2023 Q1	$854K	Buy	1,857 +346	+23%	+$165K	0.47%	76
2022 Q4	$775K	Buy	1,511 +40	+3%	+$20.3K	0.4%	89
2022 Q3	$668K	Buy	1,471 +29	+2%	+$13.9K	0.27%	125
2022 Q2	$696K	Buy	+1,442	New	+$713K	0.26%	123
2020 Q3	–	Sell	-158	Closed	-$42K	–	360
2020 Q2	$42K	Buy	158 +120	+316%	+$32K	0.02%	342
2020 Q1	$9K	Buy	+38	New	+$10.4K	﹤0.01%	393
2019 Q4	–	Sell	-175	Closed	-$42K	–	474
2019 Q3	$42K	Hold	175	–	–	0.01%	292
2019 Q2	$49K	Buy	+175	New	+$47.8K	0.01%	296

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Virtus ETF Advisers's ELV Position: Q4 2024 in Review

Virtus ETF Advisers sold out of Elevance Health (ELV) in Q4 2024, closing a stake of 1,678 shares — an estimated $873K sold.

Virtus ETF Advisers first reported a position in ELV in Q2 2019 and held it in 10 quarters. The position peaked at $873K in Q3 2024. 1,602 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

Virtus ETF Advisers reported no remaining Elevance Health position as of Q4 2024 after selling out during the quarter.
Virtus ETF Advisers sold 1,678 Elevance Health shares in Q4 2024, an estimated $873K.
Virtus ETF Advisers first reported a position in Elevance Health in Q2 2019 and held it in 10 quarters.
Virtus ETF Advisers's Elevance Health position peaked at $873K in Q3 2024.
1,602 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on Virtus ETF Advisers's 13F filing for Q4 2024, filed 14 Feb 2025.